JAK2 Exon 12 Mutation Analysis

View Test

JAK2 V617F Quantitative Mutation Analysis

View Test

JAK2 V617F Quantitative Mutation Analysis, with Reflex to Calreticulin

View Test

Joubert Syndrome Panel

  • Test Code:
    1725
  • Department:
  • Test Synonyms:
    Brain malformations Ciliopathies Seizures/Epilepsy Eye disorders AHI1 ARL13B B9D1 B9D2 C5ORF42 CC2D2A CEP290 CEP41 INPP5E KIF7 MKS1 NPHP1 NPHP3 OFD1 RPGRIP1L TCTN1 TCTN2 TMEM138 TMEM216 TMEM237 TMEM67 TTC21B
View Test

Juvenile Polyposis Syndrome (JPS), BMPR1A Sequencing

  • Test Code:
    1700
  • Department:
  • Test Synonyms:
    BMPR1A full gene sequencing Juvenile polyposis syndrome sequencing
View Test

Juvenile Polyposis Syndrome (JPS), SMAD4 Sequencing

  • Test Code:
    1710
  • Department:
  • Test Synonyms:
    SMAD4 full gene sequencing Juvenile polyposis syndrome sequencing
View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More